Luis Antonio Marques da CostaHospital de Santa Maria & Instituto de Medicina Molecular- Universidade de Lisboa, Portugal

Luís Costa, MD, PhD, is an Associate Professor of Medicine, Oncology & Oncobiology, FML-UL,

Lisbon, Portugal, and Head of the Clinical Translational Oncology Research Unit at the Institute of Molecular Medicine (IMM). Dr. Costa has also served as Director of the Oncology Department at Hospital de Santa Maria in Lisbon since 2005. At the School of Medicine, he is the Coordinator Professor of “Oncobiologia” a new teaching unit that aims to teach the understanding of clinical oncology through molecular medicine.

Prof. Costa received his MD and his PhD in Medical Oncology from the University of Lisbon. He is involved in multiple phase 1, 2 and phase 3 clinical trials in breast cancer and other solid tumors, and his research interests have long centered on the area of bone metastases. In recent years, his research has focused on understanding the molecular mechanisms of tumor progression at metastatic sites using bone metastases as a paradigm.

Prof. Costa is the director of the Clinical Research Center at Hospital de Santa Maria and is the

President of the Portuguese Association for Cancer Research (ASPIC).

Prof. Costa is Academic Editor for Plos One and Journal of Bone Oncology. He has also published more than 150 peer-reviewed articles and other publications appearing in such journals as Journal of Clinical Oncology, European Journal of Cancer, The Breast, Nature Clinical Practice Oncology, The Oncologist, Annals of Oncology, and The Lancet Oncology.